Search research articles
Contact Us
Filters
Showing results (261-270 of 270) with videos related to
Page
of 27
Sort By:
You have reached the last page of results.
This site can display upto 270 results.
Practical Radiation Oncology
|
July 17, 2019
A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal Cancer
Aurelie Garant, Thomas J Whitaker, Grant M Spears, et al.
Advances in Radiation Oncology
|
October 14, 2021
Multi-institutional Comparison of Intensity Modulated Photon Versus Proton Radiation Therapy in the Management of Squamous Cell Carcinoma of the Anus
Jahan J Mohiuddin, Krishan R Jethwa, Nikhil Grandhi, et al.
The Lancet. Oncology
|
July 9, 2017
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
Paul D Brown, Karla V Ballman, Jane H Cerhan, et al.
Practical Radiation Oncology
|
July 30, 2022
Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel
John Park, Bhanu Prasad Venkatesulu, Ksenija Kujundzic, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 27, 2019
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3)
Daniel M Trifiletti, Karla V Ballman, Paul D Brown, et al.
JAMA Oncology
|
October 20, 2022
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial
Joshua D Palmer, Brett G Klamer, Karla V Ballman, et al.
Journal of Gastrointestinal Oncology
|
November 18, 2021
Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapy
Hunter C Gits, Amy H Tang, William S Harmsen, et al.
Neuro-Oncology
|
December 6, 2022
Association of circulating markers with cognitive decline after radiation therapy for brain metastasis
Kristin Huntoon, S Keith Anderson, Karla V Ballman, et al.
Chest
|
December 16, 2023
Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy
Hunter C Gits, Mitra A Khosravi Flanigan, Jamie D Kapplinger, et al.
Cancers
|
March 29, 2023
Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design
Bradford S Hoppe, Ivy A Petersen, Benjamin K Wilke, et al.
Page
of 27
Search research articles
Search
Showing results (261-270 of 270) with videos related to
Sort By:
Page
of 27
You have reached the last page of results.
This site can display upto 270 results.
Practical Radiation Oncology
|
July 17, 2019
A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal Cancer
Aurelie Garant, Thomas J Whitaker, Grant M Spears, et al.
Advances in Radiation Oncology
|
October 14, 2021
Multi-institutional Comparison of Intensity Modulated Photon Versus Proton Radiation Therapy in the Management of Squamous Cell Carcinoma of the Anus
Jahan J Mohiuddin, Krishan R Jethwa, Nikhil Grandhi, et al.
The Lancet. Oncology
|
July 9, 2017
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
Paul D Brown, Karla V Ballman, Jane H Cerhan, et al.
Practical Radiation Oncology
|
July 30, 2022
Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel
John Park, Bhanu Prasad Venkatesulu, Ksenija Kujundzic, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 27, 2019
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3)
Daniel M Trifiletti, Karla V Ballman, Paul D Brown, et al.
JAMA Oncology
|
October 20, 2022
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial
Joshua D Palmer, Brett G Klamer, Karla V Ballman, et al.
Journal of Gastrointestinal Oncology
|
November 18, 2021
Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapy
Hunter C Gits, Amy H Tang, William S Harmsen, et al.
Neuro-Oncology
|
December 6, 2022
Association of circulating markers with cognitive decline after radiation therapy for brain metastasis
Kristin Huntoon, S Keith Anderson, Karla V Ballman, et al.
Chest
|
December 16, 2023
Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy
Hunter C Gits, Mitra A Khosravi Flanigan, Jamie D Kapplinger, et al.
Cancers
|
March 29, 2023
Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design
Bradford S Hoppe, Ivy A Petersen, Benjamin K Wilke, et al.
Page
of 27